GlassScriptPhysician profile
Aftab Mahmood
NPI 1952305591
$38,603.71
in general payments reported to CMS, 2019-2025
100 companies · $5,924 in 2025
The $5,924 reported for 2025 was more than what 84% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,758 · 2020: $3,683 · 2021: $5,029 · 2022: $7,058 · 2023: $6,170 · 2024: $5,983 · 2025: $5,924.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Education: $960 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,890.72 |
| Education | $960.39 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $225.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,602.17 | 2019-2025 | Rybrevant, Talvey, Tecvayli |
| E.R. Squibb & Sons, L.L.C. | $2,181.69 | 2019-2025 | Opdivo, Opdualag, Reblozyl |
| Novartis Pharmaceuticals Corporation | $2,008.06 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,824.06 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Exelixis INC. | $1,818.38 | 2019-2025 | Cabometyx |
| Daiichi Sankyo INC. | $1,620.62 | 2019-2025 | Enhertu, Injectafer |
| Pfizer INC. | $1,477.02 | 2019-2025 | |
| Aveo Pharmaceuticals, INC. | $1,419.17 | 2021-2025 | Fotivda |
| Genzyme Corporation | $1,387.11 | 2019-2025 | |
| Rigel Pharmaceuticals, INC. | $1,239.32 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Astrazeneca Pharmaceuticals LP | $1,195.41 | 2019-2025 | Enhertu, Imfinzi, Lynparza |
| Seagen INC. | $1,066.63 | 2019-2025 | Adcetris, Tukysa, Padcev |
| Astellas Pharma US INC | $1,037.74 | 2019-2025 | Vyloy, Xospata, Xtandi |
| Amgen INC. | $1,035.77 | 2019-2024 | Nplate, Xgeva, Evenity |
| Eisai INC. | $963.48 | 2021-2025 |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $922.38 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Mckesson Specialty Care Distribution, LLC | $857.82 | 2019-2020 | |
| Glaxosmithkline, LLC. | $719.27 | 2019-2025 | Ojjaara, Blenrep, Jemperli |
| Bayer Healthcare Pharmaceuticals INC. | $671.29 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $533.66 | 2019-2025 | Ultomiris, Soliris |
| Genentech USA, INC. | $533.48 | 2019-2025 | Polivy, Tecentriq, Gazyva |
| Lilly USA, LLC | $511.88 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Incyte Corporation | $508.00 | 2019-2025 | Jakafi, Monjuvi |
| Jazz Pharmaceuticals INC. | $487.16 | 2019-2025 | Zepzelca, Vyxeos |
| Karyopharm Therapeutics INC. | $476.51 | 2020-2025 | Xpovio |
| Blueprint Medicines Corporation | $452.22 | 2021-2025 | Ayvakit |
| Gilead Sciences, INC. | $442.74 | 2019-2025 | Trodelvy |
| Kite Pharma, INC. | $386.52 | 2021-2025 | Yescarta |
| Teva Pharmaceuticals USA, INC. | $378.32 | 2019-2021 | |
| Array Biopharma INC | $348.46 | 2021-2025 | Mektovi, Lorbrena, Braftovi |
| Takeda Pharmaceuticals U.S.A., INC. | $310.26 | 2022-2025 | Ninlaro, Hyqvia, Alunbrig |
| Regeneron Healthcare Solutions, INC. | $305.23 | 2021-2025 | Libtayo |
| Abbvie INC. | $297.36 | 2019-2025 | |
| Sobi, INC | $294.10 | 2022-2025 | |
| Puma Biotechnology, INC. | $290.43 | 2019-2025 | Nerlynx |
| Foundation Medicine, INC. | $278.02 | 2021-2023 | Foundationone Cdx |
| Emd Serono, INC. | $272.63 | 2019-2024 | Bavencio |
| Ipsen Biopharmaceuticals, INC | $264.53 | 2019-2024 | Somatuline Depot, Onivyde |
| Apellis Pharmaceuticals, INC. | $250.00 | 2022 | |
| Pharmaessentia USA Corporation | $233.59 | 2022-2025 | Besremi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $223.86 | 2019-2023 | Gilotrif |
| Janssen Pharmaceuticals, INC | $210.96 | 2019-2024 | Xarelto, Rybrevant, Erleada |
| Taiho Oncology, INC. | $210.10 | 2022-2025 | |
| Beigene USA, INC. | $207.83 | 2020-2024 | Brukinsa |
| Deciphera Pharmaceuticals INC. | $200.14 | 2021-2025 | Qinlock, Tgct, Romvimza |
| Servier Pharmaceuticals LLC | $187.31 | 2021-2025 | |
| Athenex Pharmaceutical Division, LLC | $175.00 | 2020 | |
| Adc Therapeutics America, INC. | $171.92 | 2021-2024 | |
| Kyowa Kirin, INC. | $146.22 | 2021-2025 | Poteligeo |
| Genmab U.S., INC. | $139.60 | 2023-2025 | Epkinly |
| Tempus Ai, INC | $135.64 | 2024 | |
| Springworks Therapeutics, INC. | $107.02 | 2024-2025 | Ogsiveo, Gomekli |
| Boston Scientific Corporation | $106.12 | 2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Dova Pharmaceuticals | $104.59 | 2019-2021 | |
| Geron Corporation | $101.30 | 2025 | Rytelo |
| Comsort, INC | $100.00 | 2019 | |
| Intuitive Surgical, INC. | $99.07 | 2022 | |
| Sanofi-Aventis U.S. LLC | $98.00 | 2023 | |
| Sumitomo Pharma America, INC. | $94.73 | 2023-2024 | Orgovyx |
| Tersera Therapeutics LLC | $93.00 | 2022-2025 | Zoladex |
| Immunocore Limited | $90.53 | 2023-2024 | Kimmtrak |
| Pharmacyclics LLC, An Abbvie Company | $86.29 | 2019-2023 | Imbruvica |
| Stemline Therapeutics INC. | $84.08 | 2020-2025 | Orserdu |
| Tolmar, INC. | $83.52 | 2023-2025 | Eligard, Rubraca |
| Alnylam Pharmaceuticals INC. | $79.06 | 2021-2023 | Givlaari |
| Myriad Genetic Laboratories, INC. | $78.34 | 2024 | Myrisk |
| Coherus Oncology, INC. | $76.47 | 2020-2022 | |
| Pharmaand Gmbh | $65.07 | 2025 | Rubraca |
| Heron Therapeutics, INC. | $61.04 | 2019 | |
| Pharmacosmos Therapeutics INC. | $56.89 | 2021-2025 | Monoferric |
| Sun Pharmaceutical Industries INC. | $54.91 | 2022 | |
| Verastem, INC. | $54.16 | 2019 | |
| Myovant Sciences INC. | $52.02 | 2021-2022 | |
| Beone Medicines USA, INC. | $51.11 | 2025 | Brukinsa |
| Epizyme, INC. | $50.25 | 2020-2022 | |
| Agios Pharmaceuticals, INC. | $43.46 | 2025 | Pyrukynd |
| Mylan Institutional INC. | $42.93 | 2021-2022 | |
| Morphosys, US INC. | $40.46 | 2021-2023 | Monjuvi |
| Octapharma USA, INC. | $40.00 | 2023-2024 | Panzyga, Octagam Immune Globulin (Human) |
| Tg Therapeutics, INC. | $37.61 | 2021 | |
| Mirati Therapeutics, INC. | $37.48 | 2023 | Krazati |
| Amag Pharmaceuticals, INC. | $33.08 | 2020-2021 | |
| Spectrum Pharmaceuticals INC. | $32.53 | 2024-2025 | Rolvedon |
| Invivyd INC | $31.07 | 2025 | Pemgarda |
| Immunomedics, INC. | $29.13 | 2020 | |
| Clovis Oncology, INC. | $28.95 | 2019-2021 | |
| Organon LLC | $26.56 | 2023 | Ontruzant |
| Eusa Pharma (US) LLC | $26.35 | 2019 | |
| Acceleron Pharma, INC. | $24.85 | 2021 | |
| Legend Biotech USA INC. | $23.44 | 2025 | Carvykti |
| G1 Therapeutics, INC. | $23.35 | 2023 | Cosela |
| Adaptive Biotechnologies Corporation | $22.79 | 2023 | Clonoseq |
| Global Blood Therapeutics, INC. | $22.39 | 2022 | |
| Acrotech Biopharma INC. | $22.16 | 2021 | |
| Dendreon Pharmaceuticals LLC | $21.48 | 2025 | Provenge |
| Azurity Pharmaceuticals, INC. | $19.21 | 2025 | Danziten |
| Lexicon Pharmaceuticals, INC. | $19.11 | 2019 | |
| Pharming Healthcare, INC. | $16.96 | 2024 | Ruconest |
| Recordati_rare_diseases_inc. | $16.84 | 2025 | Enjaymo |
| Tactile Systems Technology INC | $16.79 | 2024 | Flexitouch Plus, Entre Plus |
Drugs and devices associated with these payments
Keytruda $888Opdivo $719Lenvima $682Rybrevant $658Rezlidhia $556Tavalisse $556Fabhalta $533Enhertu $505Talvey $478Tecvayli $465Darzalex $436Ayvakit $413Lynparza $400Ojjaara $372Xpovio $328Sarclisa $308Reblozyl $307Nubeqa $294Zepzelca $275Xofigo $269Opdualag $268Fotivda $262Erleada $261Venclexta $258Besremi $221Ibrance $219Yescarta $210Kisqali $210Padcev $204Adcetris $191Pomalyst $190Brukinsa $187Jaypirca $186Verzenio $184Tukysa $184Libtayo $184Injectafer $177Cabometyx $170Enjaymo $170Ultomiris $168Trodelvy $168Orgovyx $157Scemblix $156Jakafi $153Carvykti $152Akeega $148Lonsurf $147Inqovi $147Epkinly $140Qinlock $138Elrexfio $133Xtandi $131Retevmo $130Doptelet $129Mektovi $125Lorbrena $125Vyloy $124Tibsovo $121Braftovi $120Polivy $120Rubraca $120Keytruda Qlex $117Therasphere Y90 Glass Microspheres 10 Gbq $106Xospata $105Rytelo $101Xalkori $98.61Elitek $98.00Imfinzi $94.34Ogsiveo $92.23Kimmtrak $90.53Welireg $87.24Eligard $83.52Tecentriq $83.46Monjuvi $78.54Myrisk $78.34Onivyde $78.16Somatuline Depot $78.16Ninlaro $77.39Bosulif $76.18Besponsa $76.18Tagrisso $74.81Poteligeo $74.59Promacta $74.04Paxlovid $73.73Nplate $73.31Xgeva $73.31Hyqvia $73.00Gazyva $72.42Lunsumio $72.42Lutathera $69.30Comirnaty $67.16Orserdu $66.93Prolia $66.30Evenity $66.30Imbruvica $64.22Alunbrig $62.00Stivarga $60.35Vitrakvi $60.35Balversa $59.68Zoladex $59.62
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aftab Mahmood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.